Lv6
2930 积分 2024-03-30 加入
Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease
5小时前
已完结
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial
3天前
已完结
Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy
3天前
已完结
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous Nephropathy
3天前
求助中
A Novel Therapy of Finerenone and Dapagliflozin for Lipoprotein Glomerulopathy
5天前
已关闭
Genetic Diagnosis in Consanguineous Families With Kidney Disease by Homozygosity Mapping Coupled With Whole-Exome Sequencing
12天前
已完结
α-Actinin-4-Mediated FSGS: An Inherited Kidney Disease Caused by an Aggregated and Rapidly Degraded Cytoskeletal Protein
12天前
已完结
Patients with ACTN4 Mutations Demonstrate Distinctive Features of Glomerular Injury
12天前
已完结
Considerations for the future: current and future treatment paradigms with mineralocorticoid receptor antagonists—unmet needs and underserved patient cohorts
12天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
12天前
已完结
皖公网安备34019202002308
